Boston Scientific hesitates to release full safety results for Watchman heart implant

March 6, 2013 by Arezu Sarvestani

Some Wall Street analysts are wary of Boston Scientific's decision to hold back some of the safety results from a trial of its Watchman stroke prevention implant.

Boston Scientific's Watchman heart implant

Officials at Boston Scientific (NYSE:BSX) announced this week that they would reveal only limited patient safety results when they present data from a clinical trial of the Watchman stroke prevention implant at the American College of Cardiology conference this week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp